Exceptional circumstances


A type of marketing authorisation granted to medicines where the applicant is unable to provide comprehensive data on the efficacy and safety under normal conditions of use, because the condition to be treated is rare or because collection of full information is not possible or is unethical.

More information is available under 'Pre-authorisation guidance: question 1.9'.